Results of a recent “proof of concept” trial on mild cognitive decline and early Alzheimer’s disease was published in May this year in medRxiv.org. Currently the medical model of treating Alzheimer’s and mild cognitive impairment is the single drug approach which has not been found to be effective.
In the trial 25 patients with Alzheimer’s disease or mild cognitive impairment aged 50 to 76 years participated in the trial. In the group were 13 women and 12 men.
All patients were evaluated with a series of tests including pathology testing, cognitive assessments, gene testing and functional medicine tests.
"My mission is to spread the word on eating well and living well to create vibrant good health. My passion is assisting my patients to feel the best they can, using a balanced, achievable and effective approach."